Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.

CONCLUSION: Here, we identified an 8-IRGP novel prognostic signature for the prediction of prostate cancer recurrence.
PMID: 32593277 [PubMed - as supplied by publisher]

Source: Combinatorial Chemistry and High Throughput Screening - June 26, 2020 Category: Chemistry Authors: Jin Y, Wang L, Lou H, Song C, He X, Ding M Tags: Comb Chem High Throughput Screen Source Type: research